Oligonucleotide squelching reveals the mechanism of estrogen receptor autologous down-regulation

Molecular Endocrinology

Volumn 11, Issue 7, 1997, Pages 938-949

  Santagati, S ^a   Gianazza, E ^a   Agrati, P ^a   Vegeto, E ^a   Patrone, C ^a   Pollio, G ^a   Maggi, A ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ESTROGEN RECEPTOR;

ARTICLE; BINDING SITE; HORMONAL REGULATION; HORMONE RESPONSIVE ELEMENT; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; RECEPTOR BINDING; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030990377     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.11.7.9936     Document Type: Article

References (52)

1. Evans RM 1988 The steroid and thyroid hormone receptor superfamily. Science 204:889-895
2. Carson-Jurica MA, Schrader WT, O'Malley BW 1990 Steroid receptor family: structure and functions. Endocr Rev 11:201-220
3. Beato M, Herrlich P, Schutz G 1995 Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
4. Green S, Chambon P 1988 Nuclear receptor enhance our understanding of transcription regulation. Trends Genet 4:304-313
5. Beato M 1989 Gene regulation by steroid hormones. Cell 58:335-344
6. Curtis SW, Korach KS 1990 Uterine estrogen receptor interaction with estrogen-responsive DNA sequences in vitro: effects of ligand binding on receptor-DNA complexes. Mol Endocrinol 4:276-286
7. Cavailles V, Dauvois S, Danielian PS, Parker MG 1994 Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci USA 91:10009-10013
8. Cavailles V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG 1995 Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:4741-3751
9. Onate SA, Tsai SY, Tsai MJ, O'Malley BW 1995 Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
10. Voegel GJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
11. Vanderbilt JN, Miesfeid R, Maler BA, Yamamoto KR 1987 Intracellular receptor concentration limits glucocorticoid dependent enhancer activity. Mol Endocrinol 1:68-74
12. Weeb P, Lopez GN, Green GL, Baxter JD, Kushner PJ 1992 The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 6:157-167
13. Speizer FE, Hennekens CH 1991 Postmenopausal estrogen therapy and cardiovascular disease. N Engl J Med 325:756-762
14. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG 1994 Estrogen replacement therapy in older women. Comparison between Alzheimer disease cases and nondemented control subjects. Arch Neurol 51:896-900
15. Alexander IE, Shine J, Sutherland RL 1990 Progestin regulation of estrogen receptor messenger RNA in human breast cancer cells. Mol Endocrinol 4:821-828
16. Saceda M, Lippman ME, Chambon P, Lindsey RL, Ponglikit-Mongkol M, Puente M, Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Mol Endocrinol 2:1157-1162
17. Berkenstam A, Glauman H, Martin M, Gustafsson J-A, Norstendt G 1989 Hormonal regulation of estrogen receptor messenger ribonucleic acid in T47Dco and MCF-7 breast cancer cells. Mol Endocrinol 3:22-28
18. Read LD, Greene GL, Katzenellenbogen BS 1989 Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Mol Endocrinol 3:295-304
19. Saceda M, Lippman ME, Lidsey RK, Puente M, Martin MB 1989 Role of an estrogen receptor-dependent mechanism in the regulation of estrogen receptor mRNA in MCF-7 cells. Mol Endocrinol 2:1782-1787
20. Kaneko KJ, Furlow JD, Gorski J 1993 Involvement of the coding sequence for the estrogen receptor gene in autologous ligand-dependent down-regulation. Mol Endocrinol 7:879-888
21. Burnstein KL, Jewell CM, Sar M, Cidlowski JA 1994 Intragenic sequences of the human glucocorticoid receptor complementary DNA mediate hormone-inducibile receptor messenger RNA down-regulation through multiple mechanisms. Mol Endocrinol 8:1764-1773
22. Toulme JJ, Helene C 1988 Anti-messenger oligodeoxyribonucleotides: an alternative to antisense RNA for artificial regulation of gene expression-a review. Gene 72:51-58
23. Uhulann E, Peyman A 1990 Antisense oligonucleotides: a new therapeutic principle. Chem Rev 90:544-583
24. Cope FO, Wille JJ 1989 Retinoic receptor antisense DNAs inhibit alkaline phophatase induction and clonogenicity in malignant keratinocytes. Proc Natl Acad Sci USA 86:5590-5594
25. Pepin MC, Barde N 1991 Decreased glucocorticoid receptor activity following glucocorticoid receptor anti-sense RNA gene fragment transfection. Mol Cell Biol 11:1647-1653
26. Pollio G, Xue P, Zanisi M, Nicolin A, Maggi A 1993 Anti-sense oligonucleotide blocks progesterone-induced lordosis behaviour in ovariectomized rats. Mol Brain Res 19:135-139
27. Lees JA, Fawell SE, Parker MG 1989 Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res 17:5477-5488
28. Munson PJ, Rodbard D 1980 LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239
29. Creighton TE 1979 Electrophoretic analysis of the unfolding of proteins by urea. Anal Biochem 129:235-264
30. Goldenberg DP, Creighton TE 1984 Gel electrophoresis in studies of protein conformation and folding. Anal Biochem 138:1-18
31. Vilanova M, Burgos FJ, Cuchillo CM, Avilés FX 1985 Urea-gradient gel electrophoresis studies on the association of procarboxypeptidases A and B, proproteinase E, and their tryptic activation products. FEBS Lett 191:273-277
32. Tyr interacts with both subunits. Proc Natl Acad Sci USA 83:1189-1192
33. Hunter I, Schulthess T, Bruch M, Beck K, Engel J 1990 Evidence for a specific mechanism of laminin assembly. Eur J Biochem 188:205-211
34. 2-antiplasmin, angiotensinogen, and ovalbumin. Biochemistry 30:1723-1730
35. Ferguson KA 1964 Starch-gel electrophoresis: application to the classification of pituitary proteins and polypeptides. Metabolism 13:985-992
36. Willard R, Benz CC, Baxter JD, Kushner P, Hunt A 1994 Paradoxical production of target protein using antisense RNA expression vectors. Gene 149:21-24
37. Brent GA, Moore DD, Larsen PR 1991 Thyroid hormone regulation of gene expression. Annu Rev Physiol 53:17-35
38. Dauvois S, Danielian PS, White R, Parker MG 1992 Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci USA 89:4037-4041
39. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW 1995 Analysis of estrogen receptor fuction in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669
40. Wen DX, Xu YF, Mais DE, Goldman ME, McDonnel DP 1995 The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells. Mol Cell Biol 14:8356-8364
41. Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273:1222-1225
42. Kushner PJ, Hort E, Shine J, Baxter JD, Greene GL 1990 Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens. Mol Endocrinol 4:1465-1473
43. Vegeto E, Cocciolo MG, Raspagliesi F, Piffanelli A, Fontanelli R, Maggi A 1990 Regulation of progesterone receptor gene expression. Cancer Res 50:5291-5298
44. Becker D, Meier CB, Herlyn M 1989 Proliferation of human malignant melanomas is inhibited by antisense oligonucleotides targeted against basic fibroblast growth factor. EMBO J 8:3685-3691
45. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
46. Patrone C, Ma ZQ, Pollio G, Agrati P, Parker MG, Maggi A 1996 Cross-coupling between insulin and estrogen receptor in human neuroblostoma cells. Mol Endocrinol 10:499-507
47. Vegeto E, Shahbaz MM, Wen DW, Goldman ME, O'Malley BW, McDonnell DP 1993 Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function. Mol Endocrinol 7:1244-1255
48. Norris J, Fan D, Aleman C, Marks JR, Futreal PA, Wiseman RW, Iglehart JD, Deininger PL, McDonnell DP 1995 Identification of a new subclass of Alu DNA repeats which can function as estrogen receptor-dependent transcriptional enhancers. J Biol Chem 270:22777-22782
49. Bettini E, Pollio G, Santagati S, Maggi A 1992 Estrogen receptor in rat brain: presence in the hippocampal formation. Neuroendocrinology 56:502-508
50. Kleine B, Löffler G, Kaufmann H, Scheipers P, Schickle H, Westermeier RA, Bessler WG 1992 Reduced chemical and radioactive liquid waste during electrophoresis using polymerized electrode gels. Elecrophoresis 13:73-75
51. Ma ZQ, Spreafico E, Pollio G, Santagati S, Cattaneo E, Maggi A (1993) Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc Natl Acad Sci USA 90:3740-3744
52. Santagati S, Bettini E, Asdente M, Muramatsu M, Maggi A 1993 Theoretical considerations for the application of competitive polymerase chain reaction to the quantitation of a low abundance mRNA: estrogen receptor. Biochem Pharmacol 46:1797-1803